4//SEC Filing
VERNON W ANTHONY 4
Accession 0001562180-24-004761
CIK 0001645113other
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 5:43 PM ET
Size
9.3 KB
Accession
0001562180-24-004761
Insider Transaction Report
Form 4
NovoCure LtdNVCR
VERNON W ANTHONY
Director
Transactions
- Award
Restricted Stock Units
2024-06-05+4,053→ 169,850 total - Sale
Ordinary Shares
2024-06-04$23.89/sh−964$23,033→ 164,833 total - Award
Stock Option (Right to Buy)
2024-06-05+6,229→ 6,229 totalExercise: $23.13Exp: 2034-06-04→ Ordinary Shares (6,229 underlying)
Footnotes (3)
- [F1]This transaction was executed in multiple trades at prices ranging from $23.78 USD to $24.00 USD; the price reported above reflects the weighted average sale price.
- [F2]These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders.
- [F3]Options to buy 6,229 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001369091
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 5:43 PM ET
- Size
- 9.3 KB